Medtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
